<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-02-01" modified="2018-01-31" version="187">
<accession>P41250</accession>
<accession>B3KQA2</accession>
<accession>B4DIA0</accession>
<accession>Q969Y1</accession>
<name>GARS_HUMAN</name>
<protein>
<recommendedName>
<fullName>Glycine--tRNA ligase</fullName>
<ecNumber evidence="21">3.6.1.17</ecNumber>
<ecNumber evidence="18">6.1.1.14</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Diadenosine tetraphosphate synthetase</fullName>
<shortName>AP-4-A synthetase</shortName>
</alternativeName>
<alternativeName>
<fullName>Glycyl-tRNA synthetase</fullName>
<shortName>GlyRS</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">GARS</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="30049" last="30055">
<title>Human glycyl-tRNA synthetase. Wide divergence of primary structure from bacterial counterpart and species-specific aminoacylation.</title>
<authorList>
<person name="Shiba K."/>
<person name="Schimmel P."/>
<person name="Motegi H."/>
<person name="Noda T."/>
</authorList>
<dbReference type="PubMed" id="7962006"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ALA-42</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Nucleic Acids Res." volume="23" first="1307" last="1310">
<title>Cloning, sequencing and bacterial expression of human glycine tRNA synthetase.</title>
<authorList>
<person name="Williams J.H."/>
<person name="Osvath S.R."/>
<person name="Khong T.-F."/>
<person name="Pearse M.J."/>
<person name="Power D.A."/>
</authorList>
<dbReference type="PubMed" id="7753621"/>
<dbReference type="DOI" id="10.1093/nar/23.8.1307"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ALA-42</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT ALA-42</scope>
<source>
<tissue>Embryo</tissue>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Nature" volume="424" first="157" last="164">
<title>The DNA sequence of human chromosome 7.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Graves T.A."/>
<person name="Pepin K.H."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Maas J."/>
<person name="Jaeger S."/>
<person name="Walker R."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="O'Laughlin M.D."/>
<person name="Schaller M.E."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Cordes M."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Edwards J."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Andrews S."/>
<person name="Isak A."/>
<person name="Vanbrunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Lamar B."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Bielicki L."/>
<person name="Scott K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Harris A."/>
<person name="Strong C.M."/>
<person name="Hou S."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Leonard S."/>
<person name="Rohlfing T."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Abbott A."/>
<person name="Minx P."/>
<person name="Maupin R."/>
<person name="Strowmatt C."/>
<person name="Latreille P."/>
<person name="Miller N."/>
<person name="Johnson D."/>
<person name="Murray J."/>
<person name="Woessner J.P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Schultz B.R."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Nelson J.O."/>
<person name="Berkowicz N."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Bedell J.A."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Chissoe S.L."/>
<person name="Marra M.A."/>
<person name="Raymond C."/>
<person name="Haugen E."/>
<person name="Gillett W."/>
<person name="Zhou Y."/>
<person name="James R."/>
<person name="Phelps K."/>
<person name="Iadanoto S."/>
<person name="Bubb K."/>
<person name="Simms E."/>
<person name="Levy R."/>
<person name="Clendenning J."/>
<person name="Kaul R."/>
<person name="Kent W.J."/>
<person name="Furey T.S."/>
<person name="Baertsch R.A."/>
<person name="Brent M.R."/>
<person name="Keibler E."/>
<person name="Flicek P."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Bailey J.A."/>
<person name="Portnoy M.E."/>
<person name="Torrents D."/>
<person name="Chinwalla A.T."/>
<person name="Gish W.R."/>
<person name="Eddy S.R."/>
<person name="McPherson J.D."/>
<person name="Olson M.V."/>
<person name="Eichler E.E."/>
<person name="Green E.D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="12853948"/>
<dbReference type="DOI" id="10.1038/nature01782"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT ALA-42</scope>
<source>
<tissue>Eye</tissue>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="28790" last="28797">
<title>Primary structure and functional expression of human glycyl-tRNA synthetase, an autoantigen in myositis.</title>
<authorList>
<person name="Ge Q."/>
<person name="Trieu E.P."/>
<person name="Targoff I.N."/>
</authorList>
<dbReference type="PubMed" id="7961834"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 3-739</scope>
<scope>VARIANT ALA-42</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="J. Neurosci." volume="26" first="10397" last="10406">
<title>Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.</title>
<authorList>
<person name="Antonellis A."/>
<person name="Lee-Lin S.Q."/>
<person name="Wasterlain A."/>
<person name="Leo P."/>
<person name="Quezado M."/>
<person name="Goldfarb L.G."/>
<person name="Myung K."/>
<person name="Burgess S."/>
<person name="Fischbeck K.H."/>
<person name="Green E.D."/>
</authorList>
<dbReference type="PubMed" id="17035524"/>
<dbReference type="DOI" id="10.1523/JNEUROSCI.1671-06.2006"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANTS CMT2D GLY-125 AND ARG-294</scope>
<scope>CHARACTERIZATION OF VARIANTS CMT2D GLY-125 AND ARG-294</scope>
<scope>VARIANTS HMN5A PRO-183; ARG-472 AND ARG-580</scope>
<scope>CHARACTERIZATION OF VARIANTS HMN5A PRO-183; ARG-472 AND ARG-580</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-204 AND LYS-501</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 AND THR-736</scope>
<scope>VARIANT [LARGE SCALE ANALYSIS] ALA-42</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2014" name="Hum. Mutat." volume="35" first="1363" last="1371">
<title>Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.</title>
<authorList>
<person name="Griffin L.B."/>
<person name="Sakaguchi R."/>
<person name="McGuigan D."/>
<person name="Gonzalez M.A."/>
<person name="Searby C."/>
<person name="Zuchner S."/>
<person name="Hou Y.M."/>
<person name="Antonellis A."/>
</authorList>
<dbReference type="PubMed" id="25168514"/>
<dbReference type="DOI" id="10.1002/humu.22681"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANTS CMT2D VAL-111; ASN-200; PHE-265; ARG-294; LEU-298; PHE-334; ARG-472; ASN-554; ARG-580 AND ALA-652</scope>
<scope>VARIANT LEU-635</scope>
<scope>CHARACTERIZATION OF VARIANTS CMT2D VAL-111; GLY-125; PRO-183; ASN-200; PHE-265; ARG-294; LEU-298; PHE-334; ARG-472; ASN-554; ARG-580 AND ALA-652</scope>
<scope>CHARACTERIZATION OF VARIANT LEU-635</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="FEBS Lett." volume="581" first="2959" last="2964">
<title>Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy.</title>
<authorList>
<person name="Cader M.Z."/>
<person name="Ren J."/>
<person name="James P.A."/>
<person name="Bird L.E."/>
<person name="Talbot K."/>
<person name="Stammers D.K."/>
</authorList>
<dbReference type="PubMed" id="17544401"/>
<dbReference type="DOI" id="10.1016/j.febslet.2007.05.046"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 55-739</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>CHARACTERIZATION OF VARIANT LEU-635</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="9976" last="9981">
<title>Long-range structural effects of a Charcot-Marie-Tooth disease-causing mutation in human glycyl-tRNA synthetase.</title>
<authorList>
<person name="Xie W."/>
<person name="Nangle L.A."/>
<person name="Zhang W."/>
<person name="Schimmel P."/>
<person name="Yang X.-L."/>
</authorList>
<dbReference type="PubMed" id="17545306"/>
<dbReference type="DOI" id="10.1073/pnas.0703908104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.85 ANGSTROMS) OF 55-739</scope>
<scope>VARIANT ARG-580</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="28968" last="28976">
<title>Crystal structures and biochemical analyses suggest a unique mechanism and role for human glycyl-tRNA synthetase in Ap4A homeostasis.</title>
<authorList>
<person name="Guo R.-T."/>
<person name="Chong Y.E."/>
<person name="Guo M."/>
<person name="Yang X.-L."/>
</authorList>
<dbReference type="PubMed" id="19710017"/>
<dbReference type="DOI" id="10.1074/jbc.M109.030692"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 55-739 IN COMPLEX WITH ATP; SUBSTRATE AND SUBSTRATE ANALOGS</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Am. J. Hum. Genet." volume="72" first="1293" last="1299">
<title>Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.</title>
<authorList>
<person name="Antonellis A."/>
<person name="Ellsworth R.E."/>
<person name="Sambuughin N."/>
<person name="Puls I."/>
<person name="Abel A."/>
<person name="Lee-Lin S.Q."/>
<person name="Jordanova A."/>
<person name="Kremensky I."/>
<person name="Christodoulou K."/>
<person name="Middleton L.T."/>
<person name="Sivakumar K."/>
<person name="Ionasescu V."/>
<person name="Funalot B."/>
<person name="Vance J.M."/>
<person name="Goldfarb L.G."/>
<person name="Fischbeck K.H."/>
<person name="Green E.D."/>
</authorList>
<dbReference type="PubMed" id="12690580"/>
<dbReference type="DOI" id="10.1086/375039"/>
</citation>
<scope>VARIANTS CMT2D GLY-125 AND ARG-294</scope>
<scope>VARIANTS HMN5A PRO-183 AND ARG-580</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Neurology" volume="67" first="1710" last="1712">
<title>Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene.</title>
<authorList>
<person name="James P.A."/>
<person name="Cader M.Z."/>
<person name="Muntoni F."/>
<person name="Childs A.M."/>
<person name="Crow Y.J."/>
<person name="Talbot K."/>
</authorList>
<dbReference type="PubMed" id="17101916"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000242619.52335.bc"/>
</citation>
<scope>VARIANT LEU-635</scope>
<scope>VARIANTS CMT2D PHE-334 AND ALA-652</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="J. Neurol. Sci." volume="263" first="100" last="106">
<title>Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome.</title>
<authorList>
<person name="Rohkamm B."/>
<person name="Reilly M.M."/>
<person name="Lochmueller H."/>
<person name="Schlotter-Weigel B."/>
<person name="Barisic N."/>
<person name="Schoels L."/>
<person name="Nicholson G."/>
<person name="Pareyson D."/>
<person name="Laura M."/>
<person name="Janecke A.R."/>
<person name="Miltenberger-Miltenyi G."/>
<person name="John E."/>
<person name="Fischer C."/>
<person name="Grill F."/>
<person name="Wakeling W."/>
<person name="Davis M."/>
<person name="Pieber T.R."/>
<person name="Auer-Grumbach M."/>
</authorList>
<dbReference type="PubMed" id="17663003"/>
<dbReference type="DOI" id="10.1016/j.jns.2007.06.047"/>
</citation>
<scope>VARIANT CMT2D VAL-111</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="J. Neurol." volume="257" first="1202" last="1204">
<title>Charcot-Marie-Tooth disease type 2D with a novel glycyl-tRNA synthetase gene (GARS) mutation.</title>
<authorList>
<person name="Hamaguchi A."/>
<person name="Ishida C."/>
<person name="Iwasa K."/>
<person name="Abe A."/>
<person name="Yamada M."/>
</authorList>
<dbReference type="PubMed" id="20169446"/>
<dbReference type="DOI" id="10.1007/s00415-010-5491-x"/>
</citation>
<scope>VARIANT CMT2D LEU-298</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2012" name="J. Peripher. Nerv. Syst." volume="17" first="418" last="421">
<title>Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V.</title>
<authorList>
<person name="Lee H.J."/>
<person name="Park J."/>
<person name="Nakhro K."/>
<person name="Park J.M."/>
<person name="Hur Y.M."/>
<person name="Choi B.O."/>
<person name="Chung K.W."/>
</authorList>
<dbReference type="PubMed" id="23279345"/>
<dbReference type="DOI" id="10.1111/j.1529-8027.2012.00442.x"/>
</citation>
<scope>VARIANTS HMN5A ASN-200 AND PHE-265</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Neurol." volume="261" first="970" last="982">
<title>Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges.</title>
<authorList>
<person name="Schabhuettl M."/>
<person name="Wieland T."/>
<person name="Senderek J."/>
<person name="Baets J."/>
<person name="Timmerman V."/>
<person name="De Jonghe P."/>
<person name="Reilly M.M."/>
<person name="Stieglbauer K."/>
<person name="Laich E."/>
<person name="Windhager R."/>
<person name="Erwa W."/>
<person name="Trajanoski S."/>
<person name="Strom T.M."/>
<person name="Auer-Grumbach M."/>
</authorList>
<dbReference type="PubMed" id="24627108"/>
<dbReference type="DOI" id="10.1007/s00415-014-7289-8"/>
</citation>
<scope>VARIANT HMN5A ARG-472</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="J. Neurol. Neurosurg. Psych." volume="85" first="1265" last="1272">
<title>Application of whole exome sequencing in undiagnosed inherited polyneuropathies.</title>
<authorList>
<person name="Klein C.J."/>
<person name="Middha S."/>
<person name="Duan X."/>
<person name="Wu Y."/>
<person name="Litchy W.J."/>
<person name="Gu W."/>
<person name="Dyck P.J."/>
<person name="Gavrilova R.H."/>
<person name="Smith D.I."/>
<person name="Kocher J.P."/>
<person name="Dyck P.J."/>
</authorList>
<dbReference type="PubMed" id="24604904"/>
<dbReference type="DOI" id="10.1136/jnnp-2013-306740"/>
</citation>
<scope>VARIANT CMT2D PHE-334</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0133423" last="E0133423">
<title>Two novel de novo gars mutations cause early-onset axonal Charcot-Marie-tooth disease.</title>
<authorList>
<person name="Liao Y.C."/>
<person name="Liu Y.T."/>
<person name="Tsai P.C."/>
<person name="Chang C.C."/>
<person name="Huang Y.H."/>
<person name="Soong B.W."/>
<person name="Lee Y.C."/>
</authorList>
<dbReference type="PubMed" id="26244500"/>
<dbReference type="DOI" id="10.1371/journal.pone.0133423"/>
</citation>
<scope>VARIANTS CMT2D TYR-200 AND ARG-292</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2015" name="Nature" volume="526" first="710" last="714">
<title>CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase.</title>
<authorList>
<person name="He W."/>
<person name="Bai G."/>
<person name="Zhou H."/>
<person name="Wei N."/>
<person name="White N.M."/>
<person name="Lauer J."/>
<person name="Liu H."/>
<person name="Shi Y."/>
<person name="Dumitru C.D."/>
<person name="Lettieri K."/>
<person name="Shubayev V."/>
<person name="Jordanova A."/>
<person name="Guergueltcheva V."/>
<person name="Griffin P.R."/>
<person name="Burgess R.W."/>
<person name="Pfaff S.L."/>
<person name="Yang X.L."/>
</authorList>
<dbReference type="PubMed" id="26503042"/>
<dbReference type="DOI" id="10.1038/nature15510"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS CMT2D GLY-125 AND ARG-294</scope>
<scope>CHARACTERIZATION OF VARIANT HMN5A PRO-183</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2016" name="Nature" volume="532" first="402" last="402">
<title>Corrigendum: CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase.</title>
<authorList>
<person name="He W."/>
<person name="Bai G."/>
<person name="Zhou H."/>
<person name="Wei N."/>
<person name="White N.M."/>
<person name="Lauer J."/>
<person name="Liu H."/>
<person name="Shi Y."/>
<person name="Dan Dumitru C."/>
<person name="Lettieri K."/>
<person name="Shubayev V."/>
<person name="Jordanova A."/>
<person name="Guergueltcheva V."/>
<person name="Griffin P.R."/>
<person name="Burgess R.W."/>
<person name="Pfaff S.L."/>
<person name="Yang X.L."/>
</authorList>
<dbReference type="PubMed" id="26789244"/>
<dbReference type="DOI" id="10.1038/nature16499"/>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="1412" last="1420">
<title>Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation.</title>
<authorList>
<person name="Oprescu S.N."/>
<person name="Chepa-Lotrea X."/>
<person name="Takase R."/>
<person name="Golas G."/>
<person name="Markello T.C."/>
<person name="Adams D.R."/>
<person name="Toro C."/>
<person name="Gropman A.L."/>
<person name="Hou Y.M."/>
<person name="Malicdan M.C.V."/>
<person name="Gahl W.A."/>
<person name="Tifft C.J."/>
<person name="Antonellis A."/>
</authorList>
<dbReference type="PubMed" id="28675565"/>
<dbReference type="DOI" id="10.1002/humu.23287"/>
</citation>
<scope>VARIANT GLN-310</scope>
<scope>CHARACTERIZATION OF VARIANT GLN-310</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2017" name="PLoS ONE" volume="12" first="E0178125" last="E0178125">
<title>Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction.</title>
<authorList>
<person name="Nafisinia M."/>
<person name="Riley L.G."/>
<person name="Gold W.A."/>
<person name="Bhattacharya K."/>
<person name="Broderick C.R."/>
<person name="Thorburn D.R."/>
<person name="Simons C."/>
<person name="Christodoulou J."/>
</authorList>
<dbReference type="PubMed" id="28594869"/>
<dbReference type="DOI" id="10.1371/journal.pone.0178125"/>
</citation>
<scope>VARIANTS ILE-268 AND CYS-412</scope>
</reference>
<comment type="function">
<text evidence="18 21 30">Catalyzes the ligation of glycine to the 3'-end of its cognate tRNA. Also produces diadenosine tetraphosphate (Ap4A), a universal pleiotropic signaling molecule needed for cell regulation pathways, by direct condensation of 2 ATPs.</text>
</comment>
<comment type="catalytic activity">
<text evidence="18 30">ATP + glycine + tRNA(Gly) = AMP + diphosphate + glycyl-tRNA(Gly).</text>
</comment>
<comment type="catalytic activity">
<text evidence="21">P(1),P(4)-bis(5'-guanosyl) tetraphosphate + H(2)O = GTP + GMP.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="18">1.3 uM for tRNA(Gly(GCC))</KM>
<KM evidence="18">15 uM for glycine</KM>
<KM evidence="30">0.74 uM for tRNA(Gly)</KM>
<text evidence="30">Kcat is 0.049 (sec-1) for aminoacylation for tRNA(Gly).</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="18 19 21">Homodimer.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-724143"/>
<interactant intactId="EBI-724143"/>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-724143"/>
<interactant intactId="EBI-8321941">
<id>Q9CZD3</id>
<label>Gars</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="16">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="16 26">Cell projection</location>
<location evidence="16 26">axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11">Secreted</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="11">Secreted</location>
<location evidence="11">exosome</location>
</subcellularLocation>
<text evidence="11 16">Secreted by motor neuron, possibly through the exosome pathway (By similarity). In transfected COS7 cells, not detected in mitochondria, nor in Golgi apparatus (PubMed:17035524).</text>
</comment>
<comment type="tissue specificity">
<text evidence="13">Widely expressed, including in brain and spinal cord.</text>
</comment>
<comment type="disease" evidence="13 16 17 20 22 24 26 27 28">
<disease id="DI-00278">
<name>Charcot-Marie-Tooth disease 2D</name>
<acronym>CMT2D</acronym>
<description>A dominant axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Nerve conduction velocities are normal or slightly reduced.</description>
<dbReference type="MIM" id="601472"/>
</disease>
<text evidence="28">The disease is caused by mutations affecting the gene represented in this entry. Contrary to the wild-type protein, CMT2D variants Gly-125 and Arg-294 strongly interact with NRP1. This interaction may compete out VEGFA binding and inhibits VEGFA-NRP1 signling which is essential for motor neuron survival, as suggested by experiments done in a mouse model.</text>
</comment>
<comment type="disease" evidence="13 16 23 25 28">
<disease id="DI-00402">
<name>Neuronopathy, distal hereditary motor, 5A</name>
<acronym>HMN5A</acronym>
<description>A disorder characterized by distal muscular atrophy mainly affecting the upper extremities, in contrast to other distal motor neuronopathies. These constitute a heterogeneous group of neuromuscular diseases caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs.</description>
<dbReference type="MIM" id="600794"/>
</disease>
<text evidence="28">The disease is caused by mutations affecting the gene represented in this entry. Contrary to the wild-type protein, HMN5A variant Pro-183 strongly interacts with NRP1. This interaction may compete out VEGFA binding and inhibits VEGFA-NRP1 signling which is essential for motor neuron survival, as suggested by experiments done in a mouse model.</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the class-II aminoacyl-tRNA synthetase family.</text>
</comment>
<comment type="caution">
<text evidence="18 26">According to a report, variant Leu-635 induces reduced activity (PubMed:17544401). According to another report, it does not affect function (PubMed:25168514).</text>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA57001" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAA86443" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<comment type="online information" name="Inherited peripheral neuropathies mutation db">
<link uri="http://www.molgen.ua.ac.be/CMTMutations/"/>
</comment>
<dbReference type="EC" id="3.6.1.17" evidence="21"/>
<dbReference type="EC" id="6.1.1.14" evidence="18"/>
<dbReference type="EMBL" id="D30658">
<property type="protein sequence ID" value="BAA06338.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U09510">
<property type="protein sequence ID" value="AAA86443.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK074524">
<property type="protein sequence ID" value="BAG51964.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK295490">
<property type="protein sequence ID" value="BAG58412.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005154">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006969">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004976">
<property type="protein sequence ID" value="AAC71652.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007722">
<property type="protein sequence ID" value="AAH07722.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007755">
<property type="protein sequence ID" value="AAH07755.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U09587">
<property type="protein sequence ID" value="AAA57001.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43564.1"/>
<dbReference type="PIR" id="A55314">
<property type="entry name" value="A55314"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001303701.1">
<property type="nucleotide sequence ID" value="NM_001316772.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002038.2">
<property type="nucleotide sequence ID" value="NM_002047.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.404321"/>
<dbReference type="PDB" id="2PME">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=55-739"/>
</dbReference>
<dbReference type="PDB" id="2PMF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=55-739"/>
</dbReference>
<dbReference type="PDB" id="2Q5H">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=55-739"/>
</dbReference>
<dbReference type="PDB" id="2Q5I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=55-739"/>
</dbReference>
<dbReference type="PDB" id="2ZT5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=55-739"/>
</dbReference>
<dbReference type="PDB" id="2ZT6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.08"/>
<property type="chains" value="A=55-739"/>
</dbReference>
<dbReference type="PDB" id="2ZT7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=55-739"/>
</dbReference>
<dbReference type="PDB" id="2ZT8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.35"/>
<property type="chains" value="A=55-739"/>
</dbReference>
<dbReference type="PDB" id="2ZXF">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A=55-739"/>
</dbReference>
<dbReference type="PDB" id="4KQE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.74"/>
<property type="chains" value="A=55-739"/>
</dbReference>
<dbReference type="PDB" id="4KR2">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.29"/>
<property type="chains" value="A=114-739"/>
</dbReference>
<dbReference type="PDB" id="4KR3">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.24"/>
<property type="chains" value="A=114-739"/>
</dbReference>
<dbReference type="PDB" id="4QEI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.88"/>
<property type="chains" value="A=118-739"/>
</dbReference>
<dbReference type="PDB" id="5E6M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.93"/>
<property type="chains" value="A/B=55-739"/>
</dbReference>
<dbReference type="PDBsum" id="2PME"/>
<dbReference type="PDBsum" id="2PMF"/>
<dbReference type="PDBsum" id="2Q5H"/>
<dbReference type="PDBsum" id="2Q5I"/>
<dbReference type="PDBsum" id="2ZT5"/>
<dbReference type="PDBsum" id="2ZT6"/>
<dbReference type="PDBsum" id="2ZT7"/>
<dbReference type="PDBsum" id="2ZT8"/>
<dbReference type="PDBsum" id="2ZXF"/>
<dbReference type="PDBsum" id="4KQE"/>
<dbReference type="PDBsum" id="4KR2"/>
<dbReference type="PDBsum" id="4KR3"/>
<dbReference type="PDBsum" id="4QEI"/>
<dbReference type="PDBsum" id="5E6M"/>
<dbReference type="ProteinModelPortal" id="P41250"/>
<dbReference type="SMR" id="P41250"/>
<dbReference type="BioGrid" id="108887">
<property type="interactions" value="90"/>
</dbReference>
<dbReference type="DIP" id="DIP-50471N"/>
<dbReference type="IntAct" id="P41250">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="MINT" id="MINT-1395438"/>
<dbReference type="STRING" id="9606.ENSP00000373918"/>
<dbReference type="DrugBank" id="DB00145">
<property type="generic name" value="Glycine"/>
</dbReference>
<dbReference type="iPTMnet" id="P41250"/>
<dbReference type="PhosphoSitePlus" id="P41250"/>
<dbReference type="SwissPalm" id="P41250"/>
<dbReference type="BioMuta" id="GARS"/>
<dbReference type="DMDM" id="313104283"/>
<dbReference type="EPD" id="P41250"/>
<dbReference type="MaxQB" id="P41250"/>
<dbReference type="PaxDb" id="P41250"/>
<dbReference type="PeptideAtlas" id="P41250"/>
<dbReference type="PRIDE" id="P41250"/>
<dbReference type="DNASU" id="2617"/>
<dbReference type="Ensembl" id="ENST00000389266">
<property type="protein sequence ID" value="ENSP00000373918"/>
<property type="gene ID" value="ENSG00000106105"/>
</dbReference>
<dbReference type="GeneID" id="2617"/>
<dbReference type="KEGG" id="hsa:2617"/>
<dbReference type="UCSC" id="uc003tbm.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2617"/>
<dbReference type="DisGeNET" id="2617"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000106105.13"/>
<dbReference type="GeneCards" id="GARS"/>
<dbReference type="GeneReviews" id="GARS"/>
<dbReference type="H-InvDB" id="HIX0006570"/>
<dbReference type="HGNC" id="HGNC:4162">
<property type="gene designation" value="GARS"/>
</dbReference>
<dbReference type="HPA" id="HPA017896"/>
<dbReference type="HPA" id="HPA019097"/>
<dbReference type="MalaCards" id="GARS"/>
<dbReference type="MIM" id="600287">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="600794">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601472">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P41250"/>
<dbReference type="OpenTargets" id="ENSG00000106105"/>
<dbReference type="Orphanet" id="99938">
<property type="disease" value="Autosomal dominant Charcot-Marie-Tooth disease type 2D"/>
</dbReference>
<dbReference type="Orphanet" id="139536">
<property type="disease" value="Distal hereditary motor neuropathy type 5"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28575"/>
<dbReference type="eggNOG" id="KOG2298">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0423">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000016949"/>
<dbReference type="HOGENOM" id="HOG000242015"/>
<dbReference type="HOVERGEN" id="HBG036190"/>
<dbReference type="InParanoid" id="P41250"/>
<dbReference type="KO" id="K01880"/>
<dbReference type="OMA" id="EPSYGID"/>
<dbReference type="OrthoDB" id="EOG091G02U0"/>
<dbReference type="PhylomeDB" id="P41250"/>
<dbReference type="TreeFam" id="TF343504"/>
<dbReference type="BRENDA" id="6.1.1.14">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-379716">
<property type="pathway name" value="Cytosolic tRNA aminoacylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-379726">
<property type="pathway name" value="Mitochondrial tRNA aminoacylation"/>
</dbReference>
<dbReference type="ChiTaRS" id="GARS">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P41250"/>
<dbReference type="GeneWiki" id="Glycine%E2%80%94tRNA_ligase"/>
<dbReference type="GenomeRNAi" id="2617"/>
<dbReference type="PMAP-CutDB" id="P41250"/>
<dbReference type="PRO" id="PR:P41250"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000106105"/>
<dbReference type="CleanEx" id="HS_GARS"/>
<dbReference type="ExpressionAtlas" id="P41250">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P41250">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005759">
<property type="term" value="C:mitochondrial matrix"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030141">
<property type="term" value="C:secretory granule"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004081">
<property type="term" value="F:bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004820">
<property type="term" value="F:glycine-tRNA ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015966">
<property type="term" value="P:diadenosine tetraphosphate biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070150">
<property type="term" value="P:mitochondrial glycyl-tRNA aminoacylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006418">
<property type="term" value="P:tRNA aminoacylation for protein translation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00774">
<property type="entry name" value="GlyRS-like_core"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.287.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.800">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR002314">
<property type="entry name" value="aa-tRNA-synt_IIb"/>
</dbReference>
<dbReference type="InterPro" id="IPR006195">
<property type="entry name" value="aa-tRNA-synth_II"/>
</dbReference>
<dbReference type="InterPro" id="IPR004154">
<property type="entry name" value="Anticodon-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR036621">
<property type="entry name" value="Anticodon-bd_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR027031">
<property type="entry name" value="Gly-tRNA_synthase/POLG2"/>
</dbReference>
<dbReference type="InterPro" id="IPR033731">
<property type="entry name" value="GlyRS-like_core"/>
</dbReference>
<dbReference type="InterPro" id="IPR009068">
<property type="entry name" value="S15_NS1_RNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR002315">
<property type="entry name" value="tRNA-synt_gly"/>
</dbReference>
<dbReference type="InterPro" id="IPR000738">
<property type="entry name" value="WHEP-TRS_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10745">
<property type="entry name" value="PTHR10745"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03129">
<property type="entry name" value="HGTP_anticodon"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00587">
<property type="entry name" value="tRNA-synt_2b"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00458">
<property type="entry name" value="WHEP-TRS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01043">
<property type="entry name" value="TRNASYNTHGLY"/>
</dbReference>
<dbReference type="SMART" id="SM00991">
<property type="entry name" value="WHEP-TRS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47060">
<property type="entry name" value="SSF47060"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52954">
<property type="entry name" value="SSF52954"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00389">
<property type="entry name" value="glyS_dimeric"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50862">
<property type="entry name" value="AA_TRNA_LIGASE_II"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00762">
<property type="entry name" value="WHEP_TRS_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51185">
<property type="entry name" value="WHEP_TRS_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0030">Aminoacyl-tRNA synthetase</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0144">Charcot-Marie-Tooth disease</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0436">Ligase</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0622">Neuropathy</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0648">Protein biosynthesis</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<feature type="chain" description="Glycine--tRNA ligase" id="PRO_0000072998">
<location>
<begin position="1"/>
<end position="739"/>
</location>
</feature>
<feature type="domain" description="WHEP-TRS" evidence="12">
<location>
<begin position="63"/>
<end position="119"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="21">
<location>
<begin position="331"/>
<end position="333"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="21">
<location>
<begin position="341"/>
<end position="346"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="21">
<location>
<begin position="457"/>
<end position="458"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="21">
<location>
<begin position="580"/>
<end position="583"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding">
<location>
<begin position="346"/>
<end position="350"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding">
<location>
<begin position="576"/>
<end position="580"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="21">
<location>
<position position="213"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="21">
<location>
<position position="299"/>
</location>
</feature>
<feature type="binding site" description="Substrate; via carbonyl oxygen" evidence="21">
<location>
<position position="435"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="204"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="11">
<location>
<position position="453"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="501"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="700"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="736"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1049402." id="VAR_054865" evidence="10 14 15 31 32 33">
<original>P</original>
<variation>A</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D; shows a reduction in aminoacylation activity; dbSNP:rs370531212." id="VAR_073187" evidence="20 26">
<original>A</original>
<variation>V</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D; phenotype overlapping with DSMA-V; complements the defect of the wild-type gene in yeast; contrary to the wild-type protein, strongly binds to NRP1 and competes with VEGFA for NRP1-binding; dbSNP:rs137852645." id="VAR_018718" evidence="13 16 26 28">
<original>E</original>
<variation>G</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In HMN5A; does not complement the defect of the wild-type gene in yeast; contrary to the wild-type protein, strongly interacts with NRP1; dbSNP:rs137852644." id="VAR_018719" evidence="13 16 26 28">
<original>L</original>
<variation>P</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D and HMN5A; shows a large reduction in aminoacylation activity." id="VAR_073188" evidence="23 26">
<original>D</original>
<variation>N</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D." id="VAR_074016" evidence="27">
<original>D</original>
<variation>Y</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D and HMN5A; shows a large reduction in aminoacylation activity; demonstrates a change in the subcellular location pattern; does not associate with granules." id="VAR_073189" evidence="23 26">
<original>S</original>
<variation>F</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with mild left ventricular posterior wall hypertrophy, exercise intolerance and lactic acidosis; unknown pathological significance; dbSNP:rs2230310." id="VAR_054866" evidence="29">
<original>T</original>
<variation>I</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D." id="VAR_074017" evidence="27">
<original>M</original>
<variation>R</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D; shows a large reduction in aminoacylation activity; does not impair transcription or translation or protein stability; contrary to the wild-type protein, strongly interacts with NRP1; dbSNP:rs137852643." id="VAR_018720" evidence="13 16 26 28">
<original>G</original>
<variation>R</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D; shows a large reduction in aminoacylation activity; demonstrates a change in subcellular location pattern; does not associate with granules; dbSNP:rs137852648." id="VAR_073190" evidence="22 26">
<original>P</original>
<variation>L</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in a patient with growth retardation, microcephaly, thinning of the corpus callosum, decreased white matter and brain stem involvement, as well as large calvaria, cerebellar vermis atrophy, dysmorphic features, prominent epicanthal folds, hypotelorism, high-arched palate, delayed motor milestones, apnea and sparse thin scalp hair; reduces to less than 1% aminoacylation activity." id="VAR_079827" evidence="30">
<original>R</original>
<variation>Q</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D; shows a large reduction in aminoacylation activity; demonstrates a change in subcellular location pattern; does not associate with granules; unknown pathological significance." id="VAR_073191" evidence="17 24 26">
<original>I</original>
<variation>F</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17159287." id="VAR_054867">
<original>R</original>
<variation>Q</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with mild left ventricular posterior wall hypertrophy, exercise intolerance and lactic acidosis; unknown pathological significance; dbSNP:rs770924455." id="VAR_079828" evidence="29">
<original>R</original>
<variation>C</variation>
<location>
<position position="412"/>
</location>
</feature>
<feature type="sequence variant" description="In HMN5A; shows a large reduction in aminoacylation activity; does not complement the defect of the wild-type gene in yeast." id="VAR_073192" evidence="16 25 26">
<original>H</original>
<variation>R</variation>
<location>
<position position="472"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D; demonstrates no change in subcellular location pattern; dbSNP:rs137852647." id="VAR_073193" evidence="26">
<original>D</original>
<variation>N</variation>
<location>
<position position="554"/>
</location>
</feature>
<feature type="sequence variant" description="In HMN5A; higher dimerization stability; loss of activity; shows a large reduction in aminoacylation activity; dbSNP:rs137852646." id="VAR_018721" evidence="13 16 19 26">
<original>G</original>
<variation>R</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="sequence variant" description="In HMN5A; unknown pathological significance; dbSNP:rs766280100." id="VAR_079829" evidence="17">
<original>G</original>
<variation>A</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; has no effect on subcellular localization; results in reduced activity; dbSNP:rs201358272." id="VAR_073194" evidence="17 18 26">
<original>S</original>
<variation>L</variation>
<location>
<position position="635"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2D; shows a large reduction in aminoacylation activity; demonstrates a change in subcellular location pattern; does not associate with granules." id="VAR_073195" evidence="17 26">
<original>G</original>
<variation>A</variation>
<location>
<position position="652"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG58412." ref="3" evidence="34">
<location>
<begin position="9"/>
<end position="18"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG51964." ref="3" evidence="34">
<original>D</original>
<variation>G</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA86443." ref="2" evidence="34">
<original>M</original>
<variation>I</variation>
<location>
<position position="530"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG51964." ref="3" evidence="34">
<original>L</original>
<variation>S</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="62"/>
<end position="64"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="65"/>
<end position="80"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="81"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="95"/>
<end position="112"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="121"/>
<end position="130"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="133"/>
<end position="136"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="152"/>
<end position="168"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="170"/>
<end position="173"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="182"/>
<end position="185"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="186"/>
<end position="191"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="194"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="199"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="211"/>
<end position="213"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="214"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="229"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="233"/>
<end position="243"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="244"/>
<end position="248"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="251"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="266"/>
<end position="268"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="276"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="283"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="287"/>
<end position="296"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="298"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="301"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="308"/>
<end position="314"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="315"/>
<end position="317"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="321"/>
<end position="330"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="339"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="344"/>
<end position="355"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="357"/>
<end position="359"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="365"/>
<end position="367"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="368"/>
<end position="370"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="372"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="378"/>
<end position="382"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="388"/>
<end position="391"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="392"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="400"/>
<end position="402"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="404"/>
<end position="420"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="424"/>
<end position="426"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="427"/>
<end position="431"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="434"/>
<end position="436"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="442"/>
<end position="451"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="454"/>
<end position="462"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="467"/>
<end position="476"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="482"/>
<end position="484"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="501"/>
<end position="507"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="512"/>
<end position="519"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="524"/>
<end position="535"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="541"/>
<end position="544"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="547"/>
<end position="550"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="552"/>
<end position="554"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="562"/>
<end position="564"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="565"/>
<end position="567"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="568"/>
<end position="570"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="573"/>
<end position="580"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="581"/>
<end position="592"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="593"/>
<end position="595"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="597"/>
<end position="600"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="603"/>
<end position="605"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="609"/>
<end position="611"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="615"/>
<end position="621"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="625"/>
<end position="627"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="628"/>
<end position="640"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="645"/>
<end position="647"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="650"/>
<end position="652"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="654"/>
<end position="663"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="668"/>
<end position="672"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="674"/>
<end position="677"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="679"/>
<end position="681"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="683"/>
<end position="688"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="689"/>
<end position="691"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="694"/>
<end position="698"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="699"/>
<end position="701"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="702"/>
<end position="710"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="712"/>
<end position="714"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="716"/>
<end position="722"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PME"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PMF"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2Q5I"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ZT5"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ZXF"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KQE"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KR3"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5E6M"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9CZD3"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00531"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12690580"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17035524"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17101916"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17544401"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17545306"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17663003"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19710017"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20169446"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23279345"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24604904"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24627108"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25168514"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26244500"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26503042"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28594869"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28675565"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7753621"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7961834"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7962006"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<sequence length="739" mass="83166" checksum="E4C001CEBF985C59" modified="2010-11-30" version="3">
MPSPRPVLLRGARAALLLLLPPRLLARPSLLLRRSLSAASCPPISLPAAASRSSMDGAGA
EEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVD
RAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDC
TMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEME
SVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPET
AQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEK
DHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKV
GISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPL
VAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEF
TIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDE
QRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYAR
TDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVE
ARYPLFEGQETGKKETIEE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>